Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Noninvasive mechanical ventilation in Valencia, Spain: from theory to practice].
Chiner E, Llombart M, Martínez-García MA, Fernández-Fabrellas E, Navarro R, Cervera A; en representación del Grupo de Trabajo de SAHS y VMNI de la Sociedad Valenciana de Neumología. Chiner E, et al. Among authors: cervera a. Arch Bronconeumol. 2009 Mar;45(3):118-22. doi: 10.1016/j.arbres.2008.04.006. Epub 2009 Feb 25. Arch Bronconeumol. 2009. PMID: 19246147 Spanish.
C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON).
Posadas T, Oscullo G, Zaldivar E, Villa C, Dobarganes Y, Girón R, Olveira C, Maíz L, García-Clemente M, Sibila O, Golpe R, Rodríguez J, Barreiro E, Rodriguez JL, Menéndez R, Prados C, de la Rosa D, Martinez-García MA; Spanish Registry of Bronchiectasis Group (RIBRON); SPANISH REGISTRY OF BRONCHIECTASIS GROUP. Posadas T, et al. Arch Bronconeumol (Engl Ed). 2021 Jan;57(1):21-27. doi: 10.1016/j.arbres.2019.12.017. Epub 2020 Apr 21. Arch Bronconeumol (Engl Ed). 2021. PMID: 32331706 English, Spanish.
IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.
Garcia-Solorio J, Núñez-Enriquez JC, Jiménez-Olivares M, Flores-Lujano J, Flores-Espino F, Molina-Garay C, Cervera A, Casique-Aguirre D, Peñaloza-Gonzalez JG, Baños-Lara MDR, García-Soto Á, Galván-Díaz CA, Olaya-Vargas A, Aguilar HF, Mata-Rocha M, Garrido-Hernández MÁ, Solís-Poblano JC, Luna-Silva NC, Cano-Cuapio LS, Aristil-Chery PM, Herrera-Quezada F, Carrillo-Sanchez K, Muñoz-Rivas A, Flores-Lagunes LL, Mendoza-Caamal EC, Villegas-Torres BE, González-Osnaya V, Jiménez-Hernández E, Torres-Nava JR, Martín-Trejo JA, Gutiérrez-Rivera ML, Espinosa-Elizondo RM, Merino-Pasaye LE, Pérez-Saldívar ML, Jiménez-Morales S, Curiel-Quesada E, Rosas-Vargas H, Mejía-Arangure JM, Alaez-Verson C. Garcia-Solorio J, et al. Among authors: cervera a. Front Oncol. 2024 Apr 3;14:1337954. doi: 10.3389/fonc.2024.1337954. eCollection 2024. Front Oncol. 2024. PMID: 38634053 Free PMC article.
227 results